These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

596 related articles for article (PubMed ID: 24586656)

  • 1. Prevalence of premorbid metabolic syndrome in Spanish adult workers using IDF and ATPIII diagnostic criteria: relationship with cardiovascular risk factors.
    Tauler P; Bennasar-Veny M; Morales-Asencio JM; Lopez-Gonzalez AA; Vicente-Herrero T; De Pedro-Gomez J; Royo V; Pericas-Beltran J; Aguilo A
    PLoS One; 2014; 9(2):e89281. PubMed ID: 24586656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Prevalence of Metabolic Syndrome and Its Components among Type 2 Diabetes Mellitus Patients at a Tertiary Hospital, Northwest Ethiopia.
    Biadgo B; Melak T; Ambachew S; Baynes HW; Limenih MA; Jaleta KN; Tachebele B; Melku M; Abebe M
    Ethiop J Health Sci; 2018 Sep; 28(5):645-654. PubMed ID: 30607080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prevalence of metabolic syndrome and Framingham cardiovascular risk scores in adult inpatients taking antipsychotics - a retrospective medical records review.
    Wysokiński A; Kowman M; Kłoszewska I
    Psychiatr Danub; 2012 Sep; 24(3):314-22. PubMed ID: 23013638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discordance of metabolic syndrome and abdominal obesity prevalence according to different criteria in Andean highlanders: A community-based study.
    Herrera-Enriquez K; Narvaez-Guerra O
    Diabetes Metab Syndr; 2017 Nov; 11 Suppl 1():S359-S364. PubMed ID: 28284909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of metabolic syndrome in type 2 diabetes mellitus using NCEP-ATPIII, IDF and WHO definition and its agreement in Gwalior Chambal region of Central India.
    Yadav D; Mahajan S; Subramanian SK; Bisen PS; Chung CH; Prasad GB
    Glob J Health Sci; 2013 Sep; 5(6):142-55. PubMed ID: 24171882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of metabolic syndrome and its components on cardiovascular disease event rates in 4900 patients with type 2 diabetes assigned to placebo in the FIELD randomised trial.
    Scott R; Donoghoe M; Watts GF; O'Brien R; Pardy C; Taskinen MR; Davis TM; Colman PG; Manning P; Fulcher G; Keech AC;
    Cardiovasc Diabetol; 2011 Nov; 10():102. PubMed ID: 22104275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Tale of Three Gorges in the Yangtze River: Comparing the Prevalence of Metabolic Syndrome According to ATPIII, WHO, and IDF Criteria and the Association with Vascular Health in Modernizing China.
    Woo KS; Hu YJ; Chook P; Wei AN; Chan R; Yin YH; Celermajer DS
    Metab Syndr Relat Disord; 2019 Apr; 17(3):137-142. PubMed ID: 30835162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of the metabolic syndrome in patients with carotid disease according to NHLBI/AHA and IDF criteria: a cross-sectional study.
    Maksimovic MZ; Vlajinac HD; Radak DJ; Marinkovic JM; Jorga JB
    BMC Cardiovasc Disord; 2012 Jan; 12():2. PubMed ID: 22292476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An examination of the prevalence of IDF- and ATPIII-defined metabolic syndrome in an Irish screening population.
    Waterhouse DF; McLaughlin AM; Sheehan F; O'Shea D
    Ir J Med Sci; 2009 Jun; 178(2):161-6. PubMed ID: 19129978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of metabolic syndrome in Gwalior region of Central India: A comparative study using NCEP ATP III, IDF and Harmonized criteria.
    Subramani SK; Mahajan S; Chauhan P; Yadav D; Mishra M; Pakkirisamy U; Prasad GBKS
    Diabetes Metab Syndr; 2019; 13(1):816-821. PubMed ID: 30641814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gender and age-related differences in patients with the metabolic syndrome in a highly endogamous population.
    Bener A; Mohammad AG; Ismail AN; Zirie M; Abdullatef WK; Al-Hamaq AO
    Bosn J Basic Med Sci; 2010 Aug; 10(3):210-7. PubMed ID: 20846127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of metabolic syndrome with International Diabetes Federation Criteria and ATP III Program in patients 65 years of age or older.
    De Luis DA; Lopez Mongil R; Gonzalez Sagrado M; Lopez Trigo JA; Mora PF; Castrodeza Sanz J;
    J Nutr Health Aging; 2010 May; 14(5):400-4. PubMed ID: 20424809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adult Treatment Panel III 2001 but not International Diabetes Federation 2005 criteria of the metabolic syndrome predict clinical cardiovascular events in subjects who underwent coronary angiography.
    Saely CH; Koch L; Schmid F; Marte T; Aczel S; Langer P; Hoefle G; Drexel H
    Diabetes Care; 2006 Apr; 29(4):901-7. PubMed ID: 16567835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An evaluation of the International Diabetes Federation definition of metabolic syndrome in Chinese patients older than 30 years and diagnosed with type 2 diabetes mellitus.
    Lu B; Yang Y; Song X; Dong X; Zhang Z; Zhou L; Li Y; Zhao N; Zhu X; Hu R
    Metabolism; 2006 Aug; 55(8):1088-96. PubMed ID: 16839846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of metabolic syndrome in Murcia Region, a southern European Mediterranean area with low cardiovascular risk and high obesity.
    Gavrila D; Salmerón D; Egea-Caparrós JM; Huerta JM; Pérez-Martínez A; Navarro C; Tormo MJ
    BMC Public Health; 2011 Jul; 11():562. PubMed ID: 21752307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of Obesity and Metabolic Syndrome in Children with Type 1 Diabetes: A Comparative Assessment Based on Criteria Established by the International Diabetes Federation, World Health Organisation and National Cholesterol Education Program.
    Yayıcı Köken Ö; Kara C; Can Yılmaz G; Aydın HM
    J Clin Res Pediatr Endocrinol; 2020 Mar; 12(1):55-62. PubMed ID: 31434460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening premorbid metabolic syndrome in community pharmacies: a cross-sectional descriptive study.
    Via-Sosa MA; Toro C; Travé P; March MA
    BMC Public Health; 2014 May; 14():487. PubMed ID: 24885099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic syndrome, glucose tolerance categories and the cardiovascular risk in Spanish population.
    Martínez-Larrad MT; Corbatón-Anchuelo A; Fernández-Pérez C; Lazcano-Redondo Y; Escobar-Jiménez F; Serrano-Ríos M
    Diabetes Res Clin Pract; 2016 Apr; 114():23-31. PubMed ID: 27103365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of different definitions of the metabolic syndrome on the prevalence of organ damage, cardiometabolic risk and cardiovascular events.
    Mancia G; Bombelli M; Facchetti R; Casati A; Ronchi I; Quarti-Trevano F; Arenare F; Grassi G; Sega R
    J Hypertens; 2010 May; 28(5):999-1006. PubMed ID: 20308922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance of two metabolic syndrome definitions in the estimation of cardiovascular disease among hypertensive patients.
    Hirota AH; Rodrigues CJ; Borges RL; Ribeiro AB; Zanella MT; Batista MC
    J Clin Hypertens (Greenwich); 2010 Aug; 12(8):588-96. PubMed ID: 20695935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.